youtube_live
Q3 2026 earnings • released • EPS beat +8.62% • Revenue beat +2.31%
See resultschevron_right
EW:NYSE
Edwards Lifesciences Corp
US$102.01
arrow_upward
+1.18%(+1.19) 1D
ኖቬም 6, 3:48:36 ከሰዓት ጂ ኤም ቲ-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EW...
Open
US$99.00
High
US$102.08
Low
US$98.50
Mkt. cap
58.80 ቢ
Avg. vol.
4.32 ሚ
Volume
2.82 ሚ
P/E ratio
57.83
52-wk high
US$104.16
52-wk low
US$74.66
EPS
US$1.76
Beta
0.85
Shares outstanding
575.00 ሚ
No. of employees
16 ሺ
Open
US$99.00
High
US$102.08
Low
US$98.50
Mkt. cap
58.80 ቢ
Avg. vol.
4.32 ሚ
Volume
2.82 ሚ
P/E ratio
57.83
52-wk high
US$104.16
52-wk low
US$74.66
EPS
US$1.76
Beta
0.85
Shares outstanding
575.00 ሚ
No. of employees
16 ሺ
News stories
From web sources and news partners
Zacks
·
ከ4 ሰዓቶች በፊት
HIMS' Q3 Earnings: Can Weight Loss Momentum Drive Performance?
Trefis
·
ከ10 ሰዓቶች በፊት
Is Edwards Lifesciences Stock Really Expensive?
TradingView
·
ከ12 ሰዓቶች በፊት
Key facts: EW beats, lifts view; TAVR meets goals; stock hits 2022 high
Profile
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
About Edwards Lifesciences Corp
CEO-
Employees16 ሺ
Founded1958
Headquartersኢርቪን, ካሊፎርኒያ, ዩናይትድ ስቴትስ
SectorHealth Care
IndustryMedical device
Websiteedwards.com